We are live on
!
Find out more
GC
Grace Capital Portfolio holdings
AUM
$168M
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter
Est. Return
+7.31%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$129M
AUM Growth
+$12.5M
(+11%)
Cap. Flow
+$1.51M
Cap. Flow
% of AUM
1.17%
Top 10 Holdings %
Top 10 Hldgs %
35.17%
Holding
250
New
36
Increased
56
Reduced
56
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$6.27M |
| 2 |
Apple
AAPL
|
+$3.49M |
| 3 |
ELUX
AKTIEB. ELECTROLUX B ADR SPNSD
ELUX
|
+$983K |
| 4 |
Madison Square Garden
MSGS
|
+$769K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$746K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$2.3M |
| 2 |
Vanguard Mega Cap Growth ETF
MGK
|
+$1.55M |
| 3 |
TD Synnex
SNX
|
+$981K |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$883K |
| 5 |
Visa
V
|
+$736K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.54% |
| 2 | Technology | 15.89% |
| 3 | Financials | 10.33% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Communication Services | 5.39% |
Similar funds
REMS
TI
NM
KM
MC
FAC
MSO
ACM
Grace Capital's Q3 2020 Portfolio in Review
As of Q3 2020, Grace Capital held 250 positions worth $129M, up 11% from $116M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Grace Capital's Q3 2020 filing shows 36 new, 56 increased, 56 reduced and 11 closed positions. Its largest new stake was Relay Therapeutics: 164,389 shares worth $7M. The largest sale was Portola Pharmaceuticals, Inc., an estimated $2.3M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
- Grace Capital's largest Q3 2020 buy was Relay Therapeutics: 164,389 shares worth $7M.
- Grace Capital added most to Apple in Q3 2020, an estimated $3.49M increase.
- Grace Capital's biggest Q3 2020 reduction was Vanguard Mega Cap Growth ETF, cutting an estimated $1.55M.
- Grace Capital fully exited Portola Pharmaceuticals, Inc. in Q3 2020, selling an estimated $2.3M.
- Grace Capital's ten largest holdings make up 35% of its $129M portfolio in Q3 2020.
- Grace Capital opened 36 new positions and closed 11 in Q3 2020.
- Grace Capital's portfolio value rose 11% quarter-over-quarter to $129M.
Based on Grace Capital's 13F filing for Q3 2020, filed 12 Nov 2020.